Ingemarson R, Thelander L
Department of Medical Biochemistry and Biophysics, Umeå University, Sweden.
Biochemistry. 1996 Jul 2;35(26):8603-9. doi: 10.1021/bi960184n.
For enzymatic activity, mouse ribonucleotide reductase must form a heterodimeric complex composed of homodimeric R1 and R2 proteins. Both substrate specificity and overall activity are regulated by the allosteric effectors ATP, dATP, dTTP, and dGTP, which bind to two different sites found on R1, the activity site and the substrate specificity site. We have used biosensor technique to directly observe the effects of these nucleotides on R1/R2 interactions. In the absence of effectors, positive cooperativity was observed with a Hill coefficient of 1.8 and a KD of 0.5 microM. In the presence of dTTP or dGTP, there was no cooperativity and subunit interaction was observed at a much lower R1 concentration. The highest R1/R2 affinity was in the presence of dATP or ATP with KDs of 0.05-0.1 microM. In all experiments, the molar stoichiometry between the subunits was close to 1:1. Our data support a model whereby binding of any of the effectors to the substrate specificity site promotes formation of the R1 dimer, which we believe is prerequisite for binding to the R2 dimer. Additional binding of either ATP (a positive effector) or dATP (a negative effector) to the activity site further increases R1/R2 association. We propose that binding of ATP or dATP to the activity site controls enzyme activity, not by changing the aggregation state of the R1/R2 proteins as proposed earlier, but rather by locally influencing the long range electron transport between the catalytic site of R1 and the tyrosyl free radical of R2.
对于酶活性而言,小鼠核糖核苷酸还原酶必须形成由同二聚体R1和R2蛋白组成的异二聚体复合物。底物特异性和总体活性均受变构效应物ATP、dATP、dTTP和dGTP的调节,这些效应物结合到R1上发现的两个不同位点,即活性位点和底物特异性位点。我们已使用生物传感器技术直接观察这些核苷酸对R1/R2相互作用的影响。在没有效应物的情况下,观察到正协同性,希尔系数为1.8,解离常数(KD)为0.5微摩尔。在dTTP或dGTP存在的情况下,没有协同性,并且在低得多的R1浓度下观察到亚基相互作用。R1/R2的最高亲和力存在于dATP或ATP存在的情况下,KD为0.05 - 0.1微摩尔。在所有实验中,亚基之间的摩尔化学计量比接近1:1。我们的数据支持一种模型,即任何效应物与底物特异性位点的结合促进R1二聚体的形成,我们认为这是与R2二聚体结合的先决条件。ATP(一种正效应物)或dATP(一种负效应物)与活性位点的额外结合进一步增加R1/R2的缔合。我们提出,ATP或dATP与活性位点的结合控制酶活性,不是如先前提出的那样通过改变R1/R2蛋白的聚集状态,而是通过局部影响R1催化位点与R2的酪氨酸自由基之间的长程电子传递。